Shares of NeuroPace, Inc. (NPCE) have gained 38.8% over the past four weeks to close the last trading session at $8.98, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $13.86 indicates a potential upside of 54.3%.The mean estimate comprises seven short-term price targets with a standard deviation of $4.14. While the lowest estimate of $8 indicates a 10.9% decline from the curren ...